Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals News
Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNAi Patent
Benzinga about 4 days ago6 Highly Shorted Takeover/LBO Targets Being Bought By Hedge Funds
about 9 days agoALNYLAM PHARMACEUTICALS, INC. Financials
about 17 days agoAlnylam Pharma (ALNY) Reports Phase 1 Trial Results Show Proof of Concept for ALN-TTR01
Street Insider about 17 days agoAlnylam Presents Final Results from a Phase I Clinical Trial of ALN-TTR01, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidosis
Benzinga about 17 days agoAlnylam Presents Final Results from a Phase I Clinical Trial of ALN-TTR01, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of Transthyretin-Mediated Amyloidosis (ATTR)
Business Wire about 17 days agoAlnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin for the treatment of TTR-mediated amyloidosis .
Alnylam to Webcast Presentation at Upcoming Investor Conferences
Business Wire about 18 days agoAlnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today announced that management will present a company overview at the 11th Annual JMP Securities Research Conference on Tuesday, May 15 at 2:30 p.m.
UPDATE: J.P. Morgan Initiates Coverage on Alnylam Pharmaceuticals
Benzinga about 19 days agoJPMorgan Starts Alnylam Pharmaceuticals (ALNY) at Overweight
Street Insider about 19 days agoAlnylam initiated with an Overweight at JPMorgan
about 19 days agoAlnylam Narrows Loss - Analyst Blog
Zacks about 23 days agoAlnylam's first quarter 2012 adjusted net loss of 16 cents per share was narrower than the year-ago loss of 38 cents
Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Focused on Development
Street Insider about 23 days agoALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
about 24 days agoAlnylam Pharmaceuticals Earnings Call scheduled for 4:30 pm ET today
about 24 days agoAlnylam Pharmaceuticals, Inc. (ALNY) Posts Narrower than Expected Q1 Loss
Street Insider about 24 days agoYou may also be interested in these ALNY related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ALNY | 10.43 | +0.00 | +0.00% | 540.59M |
| ALN | 1.25 | -0.04 | -3.10% | 43.09M |
| ALLT | 23.89 | -0.31 | -1.28% | 714.79M |
| AMTD | 17.24 | +0.19 | +1.11% | 9.458B |
| AMTC | 0.1999 | +0.00 | +0.00% | 0.6797M |
| AMT | 65.75 | -0.10 | -0.15% | 25.89B |
| AMSWA | 8.00 | +0.01 | +0.13% | 210.72M |
| AMSG | 27.47 | -0.30 | -1.08% | 859.26M |
| AMSF | 27.18 | +0.08 | +0.30% | 493.32M |
| AMSC | 3.73 | -0.08 | -2.10% | 191.80M |
